Our Products and R&D Strength address the needs of global pharmaceutical and biotech companies

With our cost effective and efficient services we have carved a niche for ourselves within a short period of the time

  • API-Intermediates
    Lacosamide, Bazedoxifene, Mirabigron, Cinacalcet, Dabigatran etexilate and many more...

  • API-Impurities
    Bazedoxifene, Dabigatran Etexilate, Valsartan, Olmesartan, Sitagliptin, Zafirlukast and many more...

  • Building Blocks
    Bicyclo compounds, Azaindoles, Thiophenes, Quinoxalines, Pyrazoles, Imidazoles and many more...

  • Process R&D Strengths
    Route Scouting, Quick process development to provide proof of concept and many more...

  • Analytical R&D Strengths
    Method development & validation, Specification development, Impurity profiling and many more...

  • Associate GMP & Non-GMP Manufacturing Strengths
    Capacity - 5 to 10 tons per month, Pressure reactions (10-18kg/cm2) and many more...

News & Events


  • NCEs & APIs: Successfully executed about Forty (40) NCEs projects & development of Eight (8) APIs in record time for global innovator and generic Pharma companies.
  • Lacosamide API (DMF Ref# 26594) successfully approved by USFDA
  • Pharma Generic Intermediates: Cost effective & robust process development for about Ten (10) Pharma Generic Intermediates from bench scale to multi-kilo scale for various MNC’s.
  • Indian patent office approved Lacosamide API process patent (Ref: 5149/CHE/2014)
  • Strategic Research Partner (SRP): Became SRP for many of the top Indian Pharma companies.

Our Responsibility

We at SPLS believe in keeping ourselves abreast with best practices of pharmaceutical industry. Strict adherence to regulatory requirements applicable to ensure confidentiality. Statutory and voluntary abidance to latest EHS norms.

Our primary responsibility as a service provider to pharmaceutical industry is to follow global Pharma business practices, adhere to regulatory requirements upholding confidentiality and EHS norms to upmost standards.


ISO 9001-2015 Certified Company

D&B D-U-N-S® Number 65-061-8049.

DSIR Recognized R&D Facility

Our Products at a Glance

API Intermediates

  • Lacosamide
  • Bazedoxifene
  • Mirabigron
  • Cinacalcet
  • Dabigatran etexilate
  • Dronerdarone
  • Flupiritine
  • Vemurafenib
  • Plerixafor

API Impurities

  • Bazedoxifene
  • Mirabigron
  • Dronedarone Hydrochloride
  • Lacosamide
  • Dabigatran Etexilate
  • Mesylate
  • Asenapine
  • Desloratadine
  • Valsartan
  • Atorvastatin

Custom Synthesis

S. No. Compound Name Cas No.
1 2,6-Dimethoxypyridine-3-carboxyiic acid 16727-43-8
2 3-Bromo-2,6-dimethoxy-pyridine 13445-16-4
3 N-(3-Hydroxypyridin-4-yl)- pivalamide 169205-93-0
4 4-Amino-3-hydroxy pyridine 52334-53-9
5 4-(Pivaloylamino) pyridine 70298-89-4
6 2-Bromo-3-formyl pyridine 128071-75-0
7 2-Cyano-3-aminopyridine 42242-11-5
8 2,5-Dibromonicotin-aldehyde 852181-11-4
9 2-Amino-5-bromo-3-iodo-pyridine 381233-96-1
10 Quinoxalin-2(1H)-one 1196-57-2
Go Top